Cytosorbents Crp (CTSO) stock news · rev $37.1M
Cytosorbents Crp (CTSO) is a medical devices company listed on US.
This CTSO news page leads with what Cytosorbents Crp filed — not a scraped headline mill.
No cached 8-K sentence for CTSO yet. We will not pad this page with generic market recap.
Latest reported CTSO revenue for 2025-12-31 was $37.1M. Net income was -$8.2M. Revenue was up 4.1% from 2024-12-31 to 2025-12-31. CTSO currently screens at market cap $28.8M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the CTSO stock page; for the tape open the quote page.
CTSO stock news FAQ
What are CTSO's latest revenue and net income?
Latest cached Cytosorbents Crp (CTSO) revenue for Dec 31, 2025 was $37.1M. Net income was -$8.2M. Statements: https://lician.com/financials/ctso
How did CTSO revenue change from the prior cached period?
Cached Cytosorbents Crp (CTSO) revenue was up 4.1% from $35.6M (Dec 31, 2024) to $37.1M (Dec 31, 2025). Statements: https://lician.com/financials/ctso
What is CTSO's market cap?
Cytosorbents Crp (CTSO) market cap is $28.8M on the latest cached fundamentals snapshot.
What kind of company is CTSO?
Cytosorbents Crp (CTSO) is a medical devices company listed on US.
Where is CTSO stock news listed?
Cached stock news for Cytosorbents Crp (CTSO) is listed at https://lician.com/news/ctso. Filings: https://lician.com/sec/ctso
Not investment advice.